5 Results for "

C-helix

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "C-helix" in MCE Product Catalog:

Cat. No.: HY-100214
CAS No.: 892772-75-7
Purity:  99.88%
Target:  

EGFR

Research Areas:  

Cancer

EAI001 is a potent, selective mutant epidermal growth factor receptor (EGFR) allosteric inhibitor with an IC50 value of 24 nM for EGFR L858R/T790M. EAI001 can be used for research of cancer .
loading...
    loading...
Cat. No.: HY-101522
CAS No.: 2089381-40-6
Purity:  99.75%
Target:  

EGFR BMX Kinase Btk MEK

Research Areas:  

Cancer

CHMFL-EGFR-202 is a potent, irreversible inhibitor of epidermal growth factor receptor (EGFR) mutant kinase, with IC50s of 5.3 nM and 8.3 nM for drug-resistant mutant EGFR T790M and WT EGFR kinases, respectively. CHMFL-EGFR-202 exhibits ~10-fold selectivity for EGFR L858R/T790M against the EGFR wild-type in cells. CHMFL-EGFR-202 adopts a covalent “DFG-in-C-helix-out” inactive binding conformation with EGFR, with strong antiproliferative effects against EGFR mutant-driven nonsmall-cell lung cancer (NSCLC) cell lines .
loading...
    loading...
Cat. No.: HY-P5497
Target:  

HIV

Research Areas:  

Others

C34 peptide is a biological active peptide. (This C34 peptide, also known as HR2, belongs to the helical region of gp41 of HIV, C-terminal heptad repeat 2 (HR2) defined as C helix or C peptide. It is known that HIV-1 enters cells by membrane fusion, C34 gp41 peptide is a potent inhibitors of HIV-1 fusion.)
loading...
    loading...
Cat. No.: HY-180161
Target:  

Raf

Research Areas:  

Cancer

B-Raf-IN-20 (Compound Z-001) is a B-RAF inhibitor with an IC50 value of 37.80 nM. B-Raf-IN-20 binds to DFG-out/C-helix-in conformation in the B-RAF kinase. B-Raf-IN-20 has anti-cancer activity against non-small cell lung cancer .
loading...
    loading...
Cat. No.: HY-100214R
CAS No.: 892772-75-7
Research Areas:  

Cancer

EAI001 (Standard) is the analytical standard of EAI001 (HY-100214). This product is intended for research and analytical applications. EAI001 is a potent, selective mutant epidermal growth factor receptor (EGFR) allosteric inhibitor with an IC50 value of 24 nM for EGFRL858R/T790M. EAI001 can be used for research of cancer .
loading...
    loading...